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Normative data for the Dutch version of the Penn
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Worry is a common symptom in various psychiatric problems and the key
symptom of generalised anxiety disorder (GAD). The Penn State Worry
Questionnaire (PSWQ) is the most widely used self-report scale for measur-
ing worry. The present study provides normative data for the Dutch version
of the PSWQ for a large community sample and a clinically referred sample
of patients with GAD. Norms are not only provided for the original 16-item
version, but also for an abbreviated 11-item version, which only consists of
the positively worded items and has been shown to be a promising alterna-
tive to the full-length version. The percentile scores obtained for the com-
munity sample and the clinical GAD sample did not show much overlap,
and this appeared true for the full-length as well as the abbreviated version
of the PSWQ. These normative data seem suitable for differentiating be-
tween normal and abnormal manifestations of worrying and for evaluating
the efficacy of treatments for GAD. (Netherlands Journal of Psychology, 65,
69-75.)
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Worry is a common symptom in various psychi-
atric problems, including anxiety, mood, and
eating disorders (Harvey,Watkins, Mansell, &
Shafran, 2004). In addition, excessive and uncon-
trollable worrying is viewed as the cardinal fea-
ture of generalised anxiety disorder (GAD;
American Psychiatric Association, 2000). To as-
sess the frequency, intensity, and uncontrollabil-
ity of worry and to evaluate the efficacy of treat-
ments for GAD, psychometrically sound assess-
ment tools are strongly needed, as well as repre-
sentative normative data for such measures. In
the case of worry and GAD, the Penn State Worry
Questionnaire (PSWQ; Meyer, Miller, Metzger, &
Borkovec, 1990) has emerged as the most widely
used self-report measure, in both research and
clinical practice.
The PSWQ was originally developed as a uni-
factorial measure, with 11 positively worded
items (e.g., ‘I worry about projects until they are
all done’) and five negatively worded items (e.g.,
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‘I never worry about anything’). Factor analytic
studies have indicated that a two-factor model
(with the positively worded items loading on the
first factor and the negatively worded items
loading on the second factor) provided a better
fit for the data than the hypothesised one-factor
model (Brown, Antony, & Barlow, 1992; Stöber,
1995; Beck, Stanley, & Zebb, 1995; Van Rijsoort,
Emmelkamp, & Vervaeke, 1999). However, more
recent research has shown that the negatively
worded items form a method factor that should
be considered a statistical artifact and is not re-
ally meaningful (Brown, 2003; Hazlett-Stevens,
Ullman, & Craske, 2004; Van der Heiden, Muris,
Bos, & Van der Molen, submitted). As such, it has
been argued that the negatively worded items
may undermine the psychometric qualities of
the PSWQ (Woods, 2006), and so it has been sug-
gested to remove these items from the scale and
to employ an abbreviated scale that only in-
cludes the positively worded items (Hazlett-
Stevens et al., 2004; Fresco, Heimberg, Mennin,
& Turk, 2002). There is indeed some evidence
indicating that such a shortened version of the
PSWQ is just as or even more reliable and valid
than its full-length counterpart (Hazlett-Stevens
et al., 2004; Fresco et al., 2002).
While many studies have investigated the reli-
ability and validity of the PSWQ (see for a re-
view: Startup & Erickson, 2006), research pre-
senting normative data for this measure is
sparse. So far, only one investigation has pro-
vided norms for the PSWQ in a community
sample (Gillis, Haaga, & Ford, 1995). Further,
normative data in clinical populations are lim-
ited to a handful of studies that reported cut-off
scores that may be helpful for discriminating
GAD patients from other patient groups (Behar,
Alcaine, Zuellig, & Borkovec, 2003; Fresco, Men-
nin, Heimberg, & Turk, 2003). The present study
was designed to provide normative data for the
Dutch version of the PSWQ for a sample from
the general population and a clinical sample of
patients with GAD. Given its potential we also
provided cut-off scores for the shortened 11-item
version of the PSWQ , for which currently no
normative data exist.
Method
Participants and procedure
In order to obtain a large and representative
sample of the general population, we ap-
proached participants in three ways. A sample of
455 participants was drawn from the Dutch
population by Flycatcher, a full-service online
research company. Effort was made to match this
sample to the demographic profile of the adult
Dutch population. Participants completed the
PSWQ as part of a larger survey in return for a
small financial reward. In addition, 340 partici-
pants filled in the PSWQ , after the question-
naire had been distributed by e-mail within the
personal networks of the first author and several
colleagues, friends, and family, and within the
networks of some of the participants themselves
(i.e., snowball sampling method). Examples of
networks where the PSWQ was administered
were sport clubs (e.g., soccer club), church com-
munities, and companies (e.g., cleaning com-
pany). Finally, 47 participants were approached
at two shopping malls in Rotterdam, the Nether-
lands, with the request to complete the PSWQ.
Participants in the last two groups did not re-
ceive a reward for their participation. The overall
sample consisted of 842 participants (379 men
and 463 women; mean age = 43.6 years, SD = 15.8;
range 16-84 years), none of whom were actually
being treated for a psychological disorder and
thus were defined as ‘non-clinical’ (Kendall &
Sheldrick, 2000; Sabshin, 1989).
Participants in the clinical sample of GAD pa-
tients completed the PSWQ as part of the stan-
dard assessment at PsyQ , a mental health care
organisation specialised in cognitive-behaviour
therapy. The diagnosis of GAD was established
using the Structured Clinical Interview for DSM-
IV (SCID I: First, Spitzer, Gibbon, & Williams,
1994), which was administered by a trained psy-
chologist. In a second diagnostic interview, the
diagnosis of GAD was confirmed by another ex-
perienced clinician. In total, 102 patients took
part in this study (26 men and 76 women; mean
age = 34.2 years, SD = 10.5, range 19-66 years).
Questionnaire
As already described in the introduction, the
PSWQ was designed to assess the intensity, ex-
cessiveness and uncontrollability of worry
(Meyer et al., 1990). Respondents are instructed
to indicate for each of the 16 items how appli-
cable they are to them, using a five-point scale
ranging from ‘not at all typical of me’ to ‘very
typical of me’. A total score is calculated by sum-
ming all items, after recoding the scores on the
five negatively worded items. As such, scores
range from 16 to 80, with higher scores repre-
senting a stronger tendency to worry. Psycho-
metric properties of the original English version
are good (Meyer et al., 1990), and this is also true
for the Dutch version of the scale (Kerkhof, Her-
mans, Figee, Laeremans, Pieters, & Aardema,
2000; Van Rijsoort, Vervaeke, & Emmelkamp,
1997; Van Rijsoort et al., 1999). In the present
study, Cronbach’s alpha values for the full-
length PSWQ were 0.92 in the community
sample and 0.83 in the clinical sample of GAD
patients. For the shortened version these values
were 0.93 and 0.87, respectively.
Results
The Statistical Package for the Social Sciences
(SPSS) was used to compute mean scores, stan-
Netherlands Journal of Psychology70
dard deviations, and percentile scores (i.e., cut-
off scores for 10 equal groups) for the full-length
PSWQ and the abbreviated 11-item PSWQ in
both the community and the clinical GAD
sample.
For the full-length version of the PSWQ , the
range of total scores in the non-clinical sample
was 17-80 (M = 42.4, SD = 11.8), for the abbrevi-
ated PSWQ the range was 11-55 (M = 25.9, SD =
9.4). Significant sex and age differences were
found for both the full-length and the abbrevi-
ated version of the PSWQ. Participants younger
than 45 years (PSWQ: M = 43.1, SD = 11.8; abbrevi-
ated PSWQ: M = 26.6, SD = 9.3) displayed signifi-
cantly higher PSWQ scores than participants
aged 45 and above (PSWQ: M = 41.4, SD = 11.6;
abbreviated PSWQ: M = 25.2, SD = 9.5) [t(840)’s
being 2.08, p < 0.05 and 2.27, p < 0.05 respec-
tively]. Further, women (PSWQ: M = 44.1, SD =
12.0; abbreviated PSWQ: M = 27.1, SD = 9.7) re-
ported significantly higher levels of worry than
men (PSWQ: M = 40.2, SD = 11.1; abbreviated
PSWQ: M = 24.5, SD = 8.8) [t(840)’s being 4.89, p <
0.01 and 4.09, p < 0.01 respectively].
In the clinical sample of patients with GAD the
range of total scores was 37-80 (M = 67.1, SD = 8.8)
for the full-length PSWQ , and 17-55 (M = 44.9,
SD = 7.8) for the abbreviated version. Here, no
significant sex and age differences were found.
Percentile scores for the full-length PSWQ are
presented for both the community and the clini-
cal sample in Table 1. Age- and sex-specific
norms for the community sample are displayed
in Table 2. For the abbreviated PSWQ , these nor-
mative data are provided in Tables 3 and 4. It is
noteworthy that for both versions of the PSWQ ,
there was hardly any overlap in the percentile
scores for the community and clinical samples
(see Tables 1 and 3). A score of 58 or 59 on the full-
length version, and a score between 35 and 39 on
the abbreviated scale appeared to differentiate
between the two samples, and thus seems to in-
dicate the boundary between normal and patho-
logical worrying.
Table 1 Cut-off scores for ten equal groups of the PSWQ in a community sample (n = 842) and a sample
of clinically referred GAD patients (n = 102)
Community sample GAD patients
Percentiles Cut-off scores Percentiles Cut-off scores
10 28
20 32
30 35
40 38
50 42
60 45
70 48
80 52
90 59 10 58
20 60
30 62
40 66
50 69
60 71
70 72
80 75
90 77
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Table 2 Cut-off scores for ten equal groups of the PSWQ scores in various age- and sex-based sub-
groups of the community sample
Women Men
Percentiles < 45
(n = 275)
≥ 45
(n = 188)
< 45
(n = 184)
≥ 45
( n = 195)
10 29 27 28 28
20 34 32 32 30
30 37 36 34 33
40 41 40 36 36
50 44 43 39 39
60 48 46 42 42
70 51 48 45 45
80 56 52 49 48
90 61 60 56 54
Table 3 Cut-off scores for ten equal groups of the abbreviated PSWQ in a community sample (n = 842)
and a sample of clinically referred GAD patients (n = 102)
Community sample Clinically referred GAD patients
Percentiles Cut-off scores Percentiles Cut-off scores
10 14
20 17
30 20
40 23
50 25
60 28
70 31
80 34 10 35
90 39 20 39
30 42
40 45
50 46
60 49
70 50
80 51
90 53
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Table 4 Cut-off scores for ten equal groups of the abbreviated PSWQ scores in various age and sex
based subgroups of the community sample
Women Men
Percentiles < 45
(n = 275)
≥ 45
(n = 188)
< 45
(n = 184)
≥ 45
(n = 195)
10 16 13 15 14
20 19 17 17 16
30 22 20 20 18
40 24 24 21 20
50 27 26 24 23
60 30 29 26 25
70 33 31 29 29
80 36 34 32 32
90 41 40 38 37
Discussion
Statistical significance testing is traditionally the
predominant way in research evaluating the effi-
cacy and effectiveness of treatments for psycho-
logical disorders.While it is important to dem-
onstrate that an intervention yields reductions
in symptoms at a ‘beyond chance’ level, it is also
essential to quantify the magnitude and mean-
ingfulness of this improvement, which is gener-
ally referred to as ‘clinical significance’. A statisti-
cally significant result could represent only
modest benefits from therapy if the within-
group variability is small or the sample size is
large (Gillis et al., 1995). Therefore, methods
have been developed for measuring the extent to
which treatments produce clinically significant
benefits. For example, Jacobson and Truax (1991)
introduced the Reliable Change Index, which
basically considers a patient to be ‘recovered’
when he/she displays improvement to a statisti-
cally reliable degree. Kendall and Grove (1988)
proposed another possibility to compare data
from treated individuals to normative data, typi-
cally collected from community samples. Such
comparisons answer the question to what extent
the treated individual, at post-treatment, is
clinically equivalent to the normative group.
Typically, these methods require normative data
for outcome measures which possess good reli-
ability and validity.
The present study provides such normative
data for the PSWQ , the most widely employed
self-report scale for measuring worry, the key
feature of GAD. For this purpose, the PSWQ was
administered in a large community sample as
well as a clinically referred sample of patients
with GAD, for which currently no such norma-
tive data are available. Normative data were not
only provided for the original 16-item version,
but also for an abbreviated version from which
the five negatively worded items have been re-
moved. This shortened version of the PSWQ has
been shown to be a promising alternative for the
full-length version (Hazlett-Stevens et al., 2004;
Fresco et al., 2002), and might overcome some of
the problematic aspects of the use of reversed
items. That is, negatively worded items can re-
duce the reliability and validity of a scale, and
frequently form a separate method factor that
has no substantive meaning (Woods, 2006),
which was also shown to be the case with the
PSWQ (Brown, 2003; Hazlett-Stevens et al.,
2004; Van der Heiden et al., submitted). Thus,
for the assessment of treatment effects it seems
most appropriate to employ the normative data
of the abbreviated version of the PSWQ.Never-
theless, it is recommended to administer the
full-length version, as the negatively worded
items may be helpful to disrupt a potential re-
sponse bias when completing the scale (Marsh,
1996).
Positive features of this study are the adequate
sample size of the community sample and the
use of a well-diagnosed clinical sample of adult
patients with GAD, the disorder for which worry
is the key symptom. Furthermore, this is the
first study that provides cut-off scores for the
PSWQ for a clinically referred sample of patients
with GAD, and the first to provide normative
data for the abbreviated version of the PSWQ for
both a community sample and a sample of GAD
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patients. Besides these strengths, a number of
limitations should also be mentioned. First, the
community sample may not be fully representa-
tive for the demographic profile of the adult
population. Second, with the exception of the
Flycatcher subsample of the community sample,
we do not know the response rate in the other
subsamples, so in this respect the representative-
ness of these populations is questionable. Never-
theless, it should be noted that the current cut-
off scores of the PSWQ compare really well with
those obtained in previous research (Behar et al.,
2003; Fresco et al., 2003; Gillis et al., 2005), and
so it seems reasonable to conclude that the nor-
mative data as provided in the current study are
suitable for identifying high worrying individu-
als and for interpreting treatment outcome re-
sults. Further, to assist clinicians in assessing
treatment progress, on which they can base their
decision to continue, adjust or terminate treat-
ment, norm groups for both the full-length and
the abbreviated PSWQ in the community sample
are presented in Table 5.
Table 5 Norm groups for the full-length and the abbreviated PSWQ
Norm group Total score full-length PSWQ Total score abbreviated PSWQ
Very low <29 <17
Low 29-38 18-23
Average 39-48 24-31
High 49-59 32-39
Very high >59 >39
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